Expectations trend
FY2028 · fiscal year ending 2028-03-28 · fmp
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
8.90 → 8.71 EPS · FY ending Mar 28, 2028 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CRUS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain financial flexibility with credit facility | A supporting condition in Cirrus Logic's published investment case. The stated target is Maintain $350M revolving credit facility. | Intact | Credit facility reduced or financial flexibility impaired | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-03-28 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a semiconductor business with a multi-year thesis centered on growth from a wider mix of products and markets. The thesis is intact, and company quality has improved, but recent revenue volatility and elevated risk make execution important.
The valuation evidence points to CRUS as cheap versus peers, while the expectations-gap measure is negative and model confidence is low. The priced-in assessment is labeled justified, with low fragility, so the evidence does not point to a strongly stretched market setup.
Near term, revenue may remain uneven: it rose to a peak and then declined, while operating expenses increased modestly. Management is on track with diversification and expense discipline, but the risk assessment is elevated and the evidence notes that peers have recently missed estimates.
The near-term thesis would weaken if management cuts guidance on the next call. Over the multi-year view, diversification across smartphones, PCs, prosumer, automotive, and metrology needs to translate into durable growth; delivery on intellectual property and engineering leverage remains less directly measured. Rate cuts or stabilization among major technology companies could support the sector backdrop, but are uncertain.
The 1-to-3-year thesis is intact, supported by management’s diversification focus and improved company quality, but revenue volatility and elevated execution risk remain key limits. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Profit margin stays near 52% next quarter. |
| Intact |
| Gross margin falls below 51% next quarter |
Gross margin: 53.72% FY2027-Q2; GAAP. Published target: 52%. The stored target says 2026-Q2; this source reports FY2027-Q2. Fiscal/calendar alignment needs review. Nov 4, 202653.72179 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating income rises to $90M by 2026-Q4 | The company manages costs to raise operating income slightly. | Improving | Operating income fails to rise above $85M by 2026-Q4 | Operating income: $132.372M FY2027-Q2; GAAP. Published target: $90.3M. The stored target says 2026-Q4; this source reports FY2027-Q2. Fiscal/calendar alignment needs review. Nov 4, 2026132,372,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to about $460M next quarter | Profit margin stays near 52% next quarter. | Intact | Revenue falls below $430M next quarter | Revenue: $559.462M FY2027-Q2; GAAP. Published target: ~$460M. The stored target says 2026-Q2; this source reports FY2027-Q2. Fiscal/calendar alignment needs review. Nov 4, 2026559,462,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$9.45 → $8.71 · observed estimates
$2.19B → $2.10B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-25 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-26 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-27 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-28 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-29 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-30 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-07-31 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-01 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-02 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-03 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-04 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-05 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-06 | $9.45 | $2,193,015,000 | 3 / 4 |
| 2026-08-07 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-08 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-09 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-10 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-11 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-12 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-13 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-14 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-15 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-16 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-17 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-18 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-19 | $8.90 | $2,117,608,000 | 3 / 4 |
| 2026-08-20 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-21 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-22 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-23 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-24 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-25 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-26 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-27 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-28 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-29 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-30 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-08-31 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-01 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-02 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-03 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-04 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-05 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-06 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-07 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-08 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-09 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-10 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-11 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-12 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-13 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-14 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-15 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-16 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-17 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-18 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-19 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-20 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-21 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-22 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-23 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-24 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-25 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-26 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-27 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-28 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-29 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-09-30 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-01 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-02 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-03 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-04 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-05 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-06 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-07 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-08 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-09 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-10 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-11 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-12 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-13 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-14 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-15 | $8.90 | $2,117,604,249 | 3 / 4 |
| 2026-10-16 | $8.75 | $2,090,686,499 | 3 / 3 |
| 2026-10-17 | $8.75 | $2,090,686,499 | 3 / 3 |
| 2026-10-18 | $8.75 | $2,090,686,499 | 3 / 4 |
| 2026-10-19 | $8.75 | $2,090,686,499 | 3 / 4 |
| 2026-10-20 | $8.75 | $2,090,686,499 | 3 / 4 |
| 2026-10-21 | $8.75 | $2,090,686,499 | 3 / 4 |
| 2026-10-22 | $8.64 | $2,090,686,499 | 3 / 4 |
| 2026-10-23 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-24 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-25 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-26 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-27 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-28 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-29 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-30 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-10-31 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-11-01 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-11-02 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-11-03 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-11-04 | $8.71 | $2,097,376,249 | 3 / 4 |
| 2026-11-05 | $8.71 | $2,097,376,249 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 1 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 3 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.